Free tool
Stocks far below their 52-week high
We cover 155 companies trading at least 50% below their own 52-week high. The median market value in the group is $12.76M. Across the group, the median move over the past trading day is 0.00%. 11% of the 152 with a 200-day average trade above it. Price change over the past year runs from −86.9% to −1.2% across the middle 80 percent of the group, with a median of −54.0%.
Other lists in this group
Table
155 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ESL.DE | EssilorLuxottica Société anonyme | $85.76B | Large cap | −39.11% |
| EL.PA | EssilorLuxottica Société anonyme | $85.31B | Large cap | −38.15% |
| BSX.DE | Boston Scientific Corporation | $69.12B | Large cap | −53.11% |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% |
| AFW.DE | Align Technology, Inc. | $11.26B | Large cap | −54.37% |
| EVT.DE | Evotec SE | $694.87M | Small cap | −45.75% |
| 2HQ0.DE | Tilray Brands, Inc. | $657.67M | Small cap | −67.56% |
| CRW.L | Craneware plc | $588.10M | Small cap | −40.83% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | $498.50M | Small cap | −90.91% |
| AGY.L | Allergy Therapeutics plc | $481.91M | Small cap | −30.00% |
| N3B.F | Anbio Biotechnology | $361.87M | Small cap | −83.42% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | $316.56M | Small cap | +47.70% |
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% |
| SANION.ST | Saniona AB (publ) | $171.29M | Small cap | −12.37% |
| ALSEN.PA | Sensorion SA | $164.03M | Small cap | −14.20% |
| CRNO-B.ST | Cereno Scientific AB (publ) | $148.23M | Small cap | −53.59% |
| SCLP.L | Scancell Holdings plc | $136.80M | Small cap | −7.62% |
| GBT.PA | Guerbet SA | $113.51M | Small cap | −61.92% |
| FARON.HE | Faron Pharmaceuticals Oy | $111.17M | Small cap | −79.42% |
| FARN.L | Faron Pharmaceuticals Oy | $110.28M | Small cap | −79.24% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $105.23M | Small cap | −60.78% |
| EAPI.PA | Euroapi S.A. | $104.85M | Small cap | −68.63% |
| ABNX.PA | ABIONYX Pharma SA | $98.59M | Micro cap | −31.34% |
| ADOC.PA | Adocia SA | $93.77M | Micro cap | −54.33% |
| OSE.PA | OSE Immunotherapeutics SA | $88.75M | Micro cap | −47.94% |
| EQL.ST | EQL Pharma AB (publ) | $87.58M | Micro cap | −67.01% |
| AB.PA | AB Science S.A. | $80.25M | Micro cap | −38.62% |
| DICOT.ST | Dicot Pharma AB | $78.22M | Micro cap | −76.06% |
| STX.L | Shield Therapeutics plc | $71.97M | Micro cap | −37.42% |
| ONCO.ST | Oncopeptides AB (publ) | $68.14M | Micro cap | −67.92% |
| MAAT.PA | MaaT Pharma SA | $65.60M | Micro cap | −33.91% |
| HEALTH.HE | Nightingale Health Oyj | $64.18M | Micro cap | −57.24% |
| V3V.DE | FamiCord AG | $58.74M | Micro cap | −61.35% |
| ALKLH.PA | Klea Holding SA | $54.74M | Micro cap | −32.00% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | $54.52M | Micro cap | +70.43% |
| EPIS-B.ST | Episurf Medical AB (publ) | $53.85M | Micro cap | +71.52% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | $52.93M | Micro cap | −46.25% |
| XSPRAY.ST | Xspray Pharma AB (publ) | $51.97M | Micro cap | −76.00% |
| CANTA.ST | Cantargia AB (publ) | $51.16M | Micro cap | −27.38% |
| HRTIS.HE | Herantis Pharma Oyj | $50.06M | Micro cap | −2.31% |
| AIFORIA.HE | Aiforia Technologies Oyj | $49.78M | Micro cap | −60.34% |
| COIL.L | Coiled Therapeutics plc | $49.30M | Micro cap | −26.92% |
| ORX.ST | Orexo AB (publ) | $48.90M | Micro cap | −35.06% |
| ABLD.PA | ABL Diagnostics Société anonyme | $44.99M | Micro cap | −46.67% |
| OSSD.ST | OssDsign AB (publ) | $44.89M | Micro cap | −73.26% |
| MPAL.L | MedPal AI PLC | $44.20M | Micro cap | −40.00% |
| ALNOV.PA | Novacyt S.A. | $42.69M | Micro cap | +7.38% |
| OPTOMED.HE | Optomed Oyj | $41.93M | Micro cap | −54.39% |
| ORT-B.ST | Ortoma AB (publ) | $37.82M | Micro cap | −66.52% |
| QLINEA.ST | Q-linea AB (publ) | $36.80M | Micro cap | −62.97% |
| BXT.DE | BioNxt Solutions Inc. | $34.26M | Micro cap | −65.52% |
| BRETEC.HE | Bioretec Oy | $33.48M | Micro cap | −98.25% |
| IMM.L | ImmuPharma plc | $31.75M | Micro cap | +89.66% |
| ALIMP.PA | Implanet S.A. | $31.22M | Micro cap | −2.68% |
| PSH0.DE | Sernova Biotherapeutics Inc | $30.82M | Micro cap | −27.68% |
| RENX.L | Renalytix Plc | $25.24M | Micro cap | −26.50% |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% |
| MAK.DE | Maternus-Kliniken Aktiengesellschaft | $22.49M | Micro cap | −22.03% |
| SCIB.ST | SciBase Holding AB (publ) | $21.47M | Micro cap | −29.25% |
| XBRANE.ST | Xbrane Biopharma AB (publ) | $19.86M | Micro cap | −72.31% |
| CLBX.L | CelLBxHealth plc | $19.30M | Micro cap | −79.17% |
| ELIC.ST | Elicera Therapeutics AB (publ) | $18.53M | Micro cap | −61.50% |
| ALZ.ST | Alzinova AB (publ) | $17.74M | Micro cap | −39.02% |
| DMYD-B.ST | Diamyd Medical AB (publ) | $16.69M | Micro cap | −90.97% |
| PRO.ST | Promimic AB (publ) | $16.46M | Micro cap | −41.38% |
| XINT.ST | Xintela AB (publ) | $16.41M | Micro cap | −51.08% |
| AELIS.PA | Aelis Farma SA | $16.34M | Micro cap | −19.22% |
| GME.DE | Geratherm Medical AG | $15.65M | Micro cap | −16.50% |
| APTA.L | Aptamer Group PLC | $15.32M | Micro cap | −62.50% |
| POXEL.PA | Poxel S.A. | $14.98M | Micro cap | −34.76% |
| ACTI.ST | Active Biotech AB (publ) | $14.50M | Micro cap | −62.00% |
| NICA.ST | Nanologica AB (publ) | $13.84M | Micro cap | −69.86% |
| PTRK.ST | Physitrack PLC | $13.83M | Micro cap | −57.58% |
| IZAFE-B.ST | iZafe Group AB (publ) | $13.66M | Micro cap | −17.57% |
| ALNFL.PA | NFL Biosciences SA | $13.30M | Micro cap | −39.12% |
| BOUL.ST | Boule Diagnostics AB (publ) | $12.76M | Micro cap | −47.36% |
| ICO.ST | Iconovo AB (publ) | $12.72M | Micro cap | −52.09% |
| LIFE.OL | Lifecare ASA | $12.52M | Micro cap | −97.23% |
| ALBPS.PA | Biophytis S.A. | $11.98M | Micro cap | −50.31% |
| SVNS.L | Solvonis Therapeutics plc | $11.56M | Micro cap | −55.64% |
| F98.F | CytoMed Therapeutics Limited | $10.76M | Micro cap | −50.30% |
| ALSGD.PA | SpineGuard SA | $10.62M | Micro cap | +8.08% |
| VIVE.ST | Vivesto AB | $10.39M | Micro cap | −57.13% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | $10.27M | Micro cap | −46.03% |
| CMOTEC-B.ST | Scandinavian ChemoTech AB | $10.10M | Micro cap | −19.74% |
| IMMNOV.ST | Immunovia AB (publ) | $10.07M | Micro cap | −70.74% |
| BIBB.ST | BiBBInstruments AB | $9.70M | Micro cap | −84.94% |
| SPAGO.ST | Spago Nanomedical AB (publ) | $9.60M | Micro cap | −54.00% |
| EXTX.OL | EXACT Therapeutics AS | $9.49M | Micro cap | −65.60% |
| CLS-B.ST | Clinical Laserthermia Systems AB (publ) | $9.27M | Micro cap | −75.86% |
| GENI.L | GENinCode Plc | $9.25M | Micro cap | −35.71% |
| ACE.ST | Ascelia Pharma AB (publ) | $8.78M | Micro cap | −88.08% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | $8.66M | Micro cap | +7.14% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | $8.30M | Micro cap | −0.39% |
| OPTI.L | OptiBiotix Health Plc | $7.93M | Micro cap | −51.91% |
| ABTEC.OL | Aqua Bio Technology ASA | $7.89M | Micro cap | −87.89% |
| PRM.L | Proteome Sciences plc | $7.53M | Micro cap | −44.39% |
| ERMA.ST | Enorama Pharma AB (publ) | $7.06M | Micro cap | −67.04% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | $7.05M | Micro cap | −19.44% |
| CHOSA.ST | Chosa Oncology AB | $7.01M | Micro cap | −9.00% |
| VRCI.L | Verici Dx plc | $6.99M | Micro cap | −57.14% |
| SYNT.ST | SyntheticMR AB (publ) | $6.88M | Micro cap | −74.29% |
| OBD.L | Oxford BioDynamics Plc | $6.85M | Micro cap | −74.11% |
| STENO.CO | Stenocare A/S | $6.36M | Micro cap | −22.91% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | $6.35M | Micro cap | −85.49% |
| PEXA-B.ST | PExA AB (publ) | $6.18M | Micro cap | +79.47% |
| SBX.DE | SynBiotic SE | $6.15M | Micro cap | −76.63% |
| NFX.L | Nuformix plc | $5.85M | Micro cap | +80.68% |
| ALPAT.PA | Plant Advanced Technologies SA | $5.71M | Micro cap | −53.33% |
| QLIFE.ST | Qlife Holding AB (publ) | $5.65M | Micro cap | −52.47% |
| NEOLA.ST | Neola Medical AB (publ) | $5.57M | Micro cap | −79.24% |
| BIOSGN.ST | Biosergen AB (publ) | $5.31M | Micro cap | −94.62% |
| ODI.ST | ODI Pharma AB (publ) | $5.24M | Micro cap | +39.24% |
| SERV.ST | Servana AB | $5.18M | Micro cap | +106.67% |
| ALPRE.PA | Predilife S.A. | $5.10M | Micro cap | −65.74% |
| ALBLU.PA | Bluelinea Société Anonyme | $4.29M | Micro cap | −68.11% |
| FDBK.L | Feedback plc | $4.08M | Micro cap | −48.30% |
| INDCT.OL | Induct AS | $3.74M | Micro cap | −78.07% |
| PMED.ST | PEPTONIC medical AB (publ) | $3.47M | Micro cap | −25.00% |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | $3.19M | Micro cap | −93.99% |
| FUM.L | Futura Medical plc | $3.16M | Micro cap | −95.67% |
| GUARD.ST | Disruptive Pharma AB (publ) | $3.11M | Micro cap | −93.53% |
| BSFA.L | BSF Enterprise Plc | $3.03M | Micro cap | −48.89% |
| PROGEN.ST | Prostatype Genomics AB (publ) | $2.80M | Micro cap | −79.42% |
| VAL.L | ValiRx plc | $2.78M | Micro cap | −73.04% |
| ZENI.ST | Zenicor Medical Systems AB (publ) | $2.61M | Micro cap | −59.79% |
| SPEC.ST | SpectraCure AB (publ) | $2.56M | Micro cap | −81.77% |
| IBAI.L | Imaging Biometrics Ltd. | $2.35M | Micro cap | +2.42% |
| POLAR.ST | PolarCool AB (publ) | $2.23M | Micro cap | −67.96% |
| GABA.ST | Gabather AB (publ) | $2.23M | Micro cap | −17.20% |
| VSD-B.ST | Vibrosense Dynamics AB (publ) | $2.22M | Micro cap | −58.08% |
| PHAL.ST | PharmaLundensis AB | $2.14M | Micro cap | +37.83% |
| ATORX.ST | Alligator Bioscience AB (publ) | $1.88M | Micro cap | −99.27% |
| IMS.ST | Invent Medic Sweden AB (publ) | $1.81M | Micro cap | −22.48% |
| APTA.ST | Aptahem AB (publ) | $1.50M | Micro cap | −67.65% |
| MONI.ST | Monivent AB | $1.48M | Micro cap | −37.02% |
| NANECH.ST | NanoEcho AB (publ) | $1.42M | Micro cap | −72.03% |
| CHLL.L | Chill Brands Group PLC | $1.42M | Micro cap | −87.88% |
| ALINT.PA | IntegraGen SA | $1.38M | Micro cap | −36.25% |
| 2CUREX.ST | 2cureX AB (publ) | $1.34M | Micro cap | −71.79% |
| ODIN.ST | Odinwell AB (publ) | $1.21M | Micro cap | −61.25% |
| PTP.DE | Pentixapharm Holding AG | $1.06M | Micro cap | +5.47% |
| LXB.ST | Luxbright AB (publ) | $976.04K | Micro cap | −91.76% |
| MAGLE.ST | Magle Chemoswed Holding AB (publ) | $966.89K | Micro cap | −98.15% |
| ISAB.ST | Inhalation Sciences Sweden AB (publ) | $765.95K | Micro cap | −73.58% |
| TRLS.L | Trellus Health plc | $701.41K | Micro cap | −94.29% |
| S2M.ST | S2Medical AB (publ) | $550.90K | Micro cap | −63.08% |
| NIDHOG.ST | Nidhogg Resources Holding AB (publ) | $506.85K | Micro cap | −72.69% |
| ALSAF.PA | Safe Orthopaedics SA | $148.67K | Micro cap | −73.33% |
| SDET.ST | SensoDetect Aktiebolag (publ) | $148.56K | Micro cap | −99.53% |
| ALNEV.PA | Neovacs S.A. | $22.00 | Micro cap | −11.29% |
| ADXN.SW | Addex Therapeutics Ltd | — | — | −55.21% |
| COPN.SW | Cosmo NV | — | — | −5.27% |
| MMTX.SW | MindMaze Therapeutics Holding SA | — | — | −84.98% |
| NWRN.SW | Newron Pharmaceuticals S.p.A. | — | — | +44.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.